U.S. In Vitro Fertilization Market Analysis Report 2024-2030: Societal Norms and Attitudes Shift, Driving IVF Demand
U.S. In Vitro Fertilization Market
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report by Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The U.S. in vitro fertilization market size is anticipated to reach USD 7.24 billion by 2030, expanding at a CAGR of 4.4% from 2024 to 2030
The rising prevalence of infertility among couples, the continuous advancements in IVF technology and techniques, and the shift in societal norms and attitudes toward family have significantly contributed to the increasing demand for IVF services in the U.S.
The regulatory landscape surrounding assisted reproductive technologies, including IVF, also influences market dynamics. Regulations governing IVF practices, clinic accreditation standards, and ethical considerations impact the accessibility and quality of IVF services in the U.S. Changes in regulations can either facilitate or hinder market growth by affecting factors such as treatment costs, clinic operations, and patient safety.
Increased public awareness about infertility issues and available treatment options has played a crucial role in driving the growth of the U.S. IVF market. Educational campaigns, media coverage, and advocacy efforts have helped destigmatize infertility and promote understanding about fertility treatments like IVF. Greater awareness empowers individuals to make informed decisions about seeking fertility assistance through IVF.
U.S. In Vitro Fertilization Market Report Highlights
Based on instruments, the culture media segment dominated the market with around 40% share in 2023 owing to as availability of funding and an increase in research activities
The disposable devices segment is expected to grow at the fastest CAGR over the forecast period
Based on procedure type, the fresh non-donor segment held the largest market share of over 45% in 2023. Fresh cycles are often perceived as more cost-effective due to potentially requiring fewer treatment cycles to achieve a successful pregnancy
Frozen donors are expected to register the fastest CAGR during the forecast period owing to the convenience and flexibility offered by them
The fertility clinics segment dominated the market with around 80% share in 2023 and is expected to grow at the fastest CAGR over the forecast period
The increasing demand for ART treatments has led to a significant rise in the number of fertility clinics and ART centers
In October 2023, Merck & Co. announced the launch of Fertility benefit program with the aim to provide financial services to employees for fertility treatments. The range of services includes IVF treatments, fertility tests, and hormonal treatments
Companies Featured
Bayer AG
Cook Medical LLC
EMD Serono, Inc.
Ferring B.V.
FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
Genea Biomedx
EMD Serono, Inc. (Merck KGaA)
Merck & Co., Inc.
The Cooper Companies, Inc.
Thermo Fisher Scientific, Inc.
Vitrolife
Nova IVF
RMA Network (Reproductive Medicine Associates)
U.S. Fertility
Key Attributes:
Report Attribute | Details |
No. of Pages | 70 |
Forecast Period | 2023 - 2030 |
Estimated Market Value (USD) in 2023 | $5.28 Billion |
Forecasted Market Value (USD) by 2030 | $7.24 Billion |
Compound Annual Growth Rate | 4.4% |
Regions Covered | United States |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Instrument Outlook
2.2.2. Procedure Type
2.2.3. End-use
2.3. Competitive Insights
Chapter 3. U.S. In Vitro Fertilization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. In Vitro Fertilization Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
Chapter 4. U.S. In Vitro Fertilization Market: Instrument Estimates & Trend Analysis
4.1. Instrument Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. In Vitro Fertilization Market by Instrument Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Disposable Media
4.4.2. Culture Media
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.2. Cryopreservation Media
4.4.2.3. Embryo Culture Media
4.4.2.4. Ovum Processing Media
4.4.2.5. Sperm Processing Media
4.4.3. Capital Equipment
4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.2. Sperm Analyzer Systems
4.4.3.3. Imaging Systems
4.4.3.4. Ovum Aspiration Pumps
4.4.3.5. Micromanipulator Systems
4.4.3.6. Incubators
4.4.3.7. Gas Analyzers
4.4.3.8. Laser Systems
4.4.3.9. Cryosystems
4.4.3.10. Sperm Separation Devices
4.4.3.11. IVF Cabinets
4.4.3.12. Anti-vibration Tables
4.4.3.13. Witness Systems
Chapter 5. U.S. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis
5.1. Procedure Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. In Vitro Fertilization Market by Procedure Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Fresh Donor
5.4.2. Frozen Donor
5.4.3. Fresh Non-donor
5.4.4. Frozen Non-donor
Chapter 6. U.S. In Vitro Fertilization Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. In Vitro Fertilization Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Fertility Clinics
6.4.2. Hospitals & Others Setting
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of Key Distributors and Channel Partners
7.3.2. Key Customers
7.3.3. Key Company Heat Map Analysis, 2023
7.4. Company Profiles
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
For more information about this report visit https://www.researchandmarkets.com/r/qobo12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900